Tatsuya Yamashita

发表

Evaluation of eligibility criteria in living donor liver transplantation for hepatocellular carcinoma by α-SMA-positive cancer-associated fibroblasts

O. Matsui, S. Kaneko, Y. Nakanuma, 2013, Oncology reports.

Diffusion Weighted Imaging and Intravoxel Incoherent Motion Magnetic Resonance Imaging are Potential Lenvatinib Treatment Response Biomarkers for Advanced Hepatocellular Carcinoma

T. Yamashita, K. Arai, Satoshi Kobayashi, 2022 .

Programmed cell death-1 is involved with peripheral blood immune cell profiles in patients with hepatitis C virus antiviral therapy

M. Honda, Noriho Iida, E. Mizukoshi, 2024, PloS one.